1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Preimplantation Genetic Diagnosis Market - Asia Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Preimplantation Genetic Diagnosis Industry in Asia: Forecasts to 2023

  • March 2016
  • 114 pages
  • ID: 4047930
In this report:
The aneuploidy screening segment accounted for the largest share of ##% of the PGD market in Asia in 2014.
PGD is an evolving technique that provides a practical alternative to prenatal diagnosis and termination of pregnancy for couples who are at substantial risk of transmitting a serious genetic disorder to their offspring.

Summary

Table of Contents

Preimplantation genetic diagnosis is the inspection of an embryo in vitro in order to eliminate a genetic condition in case a high risk of that condition is known. PGD is an evolving technique that offers a practical alternative to prenatal diagnosis and termination of pregnancy for couples who are at substantial risk of transmitting a serious genetic disorder to their offspring. Increasing incidence of infertility across the globe is the main driver of the PGD market. Preimplantation genetic diagnosis plays an crucial role in the detection and determination of genetic disorders, sex-linked diseases, and chromosomal abnormalities in the embryo before IVF can be performed. Growing incidence of infertility along increasing awareness about IVF and PGD is the main factor driving the PGD market in Asia.

The preimplantation genetic diagnosis market in Asia has been divided on the basis of test type, consuemr, and territory. Established on test type, the sector has been split into aneuploidy screening, chromosomal aberrations, gender selection, HLA typing, single gene disorder, and X-linked diseases. The market analysis is based on market value and estimate in terms of US$ Mn for the period 2013 to 2023 along with the CAGR for the period 2015 to 2023, considering 2014 as the base year. The aneuploidy screening segment accounted for the most important share of 35.0 percent of the PGD market in Asia in 2014. Established on consuemr, the industry has been divided into fertility clinics, health care facilities (including hospitals, diagnostic centers, and health care facilities), and academic institutes and research centers.

The section 'market overview' of this report demonstrates main market dynamics including drivers, market restraints, and alternatives that impact the current and future status of the industry. The market survey part includes Porter's Five Forces Analysis, overview of PGD, Regulatory Policies and Legality Framework for PGD, Heat Map Analysis for main market players, and country-wise number of PGD Centers in Asia. The study offers an exhaustive industry analysis of the preimplantation genetic diagnosis market in Asia with the help of Analysis of market appeal, by area, for the year 2014.

The sector has been analyzed for Asia covering South Eastern Asia, Eastern Asia, Southern Asia, Central Asia, and Western Asia. The market value and forecast of the regional and country-wise markets is provided for the period 2013 to 2023. Compound annual growth rate for each area is also estimated for the period 2015 to 2023, considering 2014 as the base year. South Eastern Asia includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Rest of SEA. Eastern Asia comprises China (CN), Japan (JP), South Korea, and Rest of Eastern Asia. Southern Asia constitutes India (IN), Sri Lanka, and Rest of Southern Asia. Western Asia includes Israel, Turkey, Jordan, Saudi Arabia (SA), the United Arab Emirates, and Rest of Western Asia. Eastern Asia accounted for the biggest share of the PGD market in Asia.

The analysis also offers recommendations for market actors and new sector entrants. These recommendations would enable existing market players to expand their market shares and help additional companies to establish their presence in the PGD market in Asia. The market research closes with the company profiles section, which comprises top information about top actors in the segment including financial overview, strategic management, and recent evolutions. Top actors in this sector are Genesis Genetics, Genea Limited, Illumina, Incorporated, Laboratory Corporation of America Holdings, Natera, Incorporated, PerkinElmer, Incorporated, Quest Diagnostics Incorporated, Reprogenetics, and Reproductive Genetics Innovations LLC. The market share analysis of main players involved the study of company products or services portfolio, post sales services and maintenance, sales revenue, and its geographical presence.

The PGD market in Asia has been splitting as follows:

Asia Preimplantation Genetic Diagnosis Market, by Test Type

China (CN)

Japan (JP)

South Korea (KR)

Rest of Eastern Asia

Southern Asia

India (IN)

Saudi arabia (SA)

United Arab Emirates

Rest of Western Asia

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
2018 Tumor Marker Testing Analyzers and Reagents Market: Supplier Shares and Sales Segment Forecasts by Product--US, Europe, Japan--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

2018 Tumor Marker Testing Analyzers and Reagents Market: Supplier Shares and Sales Segment Forecasts by Product--US, Europe, Japan--Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 21100
  • Industry report
  • June 2018
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.Highlights- Identifies and evaluates major business opportunities emerging in the tumor markermarket during ...

2018 Global Cancer Diagnostics Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Global Cancer Diagnostics Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 21100
  • Industry report
  • June 2018
  • by Venture Planning Group

The new report is a seven-country strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the U.S., five ...

2018 Global Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

2018 Global Tumor Marker Testing Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • $ 17500
  • Industry report
  • September 2018
  • by Venture Planning Group

Highlights- Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years.- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...


ref:plp2016

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on